
A new prospective study suggested that the use of prescription marijuana in older patients with hypertension was associated with a reduction in systolic and diastolic blood pressure after administration.
“Older adults are the fastest growing group of medical cannabis users, yet evidence on cardiovascular safety for this population is scarce,” Dr. Ran Abuhasira of the BGU Faculty of Health Sciences in Israel, and the BGU-Soroka Cannabis Clinical Research Institute, said in a press release. “This study is part of our ongoing effort to provide clinical research on the actual physiological effects of cannabis over time.”
To assess the impact of cannabis use on bloods pressure, heart rate, and metabolic parameters in older adults with hypertension, the researchers enrolled 26 patients (mean age 70.42 years, 53.8% female) in a prospective study who had a new prescription for cannabis. The researchers then performed 24-hour ambulatory blood pressure monitoring, ECGs, blood tests, and anthropometric measurements prior to the initiation of cannabis therapy, and again at three months after therapy. The primary outcome of interest was mean change in 24-hour blood pressure at three months.